BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

405 related articles for article (PubMed ID: 16150249)

  • 1. High-dose methadone maintenance in pregnancy: maternal and neonatal outcomes.
    McCarthy JJ; Leamon MH; Parr MS; Anania B
    Am J Obstet Gynecol; 2005 Sep; 193(3 Pt 1):606-10. PubMed ID: 16150249
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Outcomes of neonates conceived on methadone maintenance therapy.
    McCarthy JJ; Leamon MH; Stenson G; Biles LA
    J Subst Abuse Treat; 2008 Sep; 35(2):202-6. PubMed ID: 18077124
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predicting length of treatment for neonatal abstinence syndrome in methadone-exposed neonates.
    Seligman NS; Salva N; Hayes EJ; Dysart KC; Pequignot EC; Baxter JK
    Am J Obstet Gynecol; 2008 Oct; 199(4):396.e1-7. PubMed ID: 18928986
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High-dose methadone in pregnant women and its effect on duration of neonatal abstinence syndrome.
    Lim S; Prasad MR; Samuels P; Gardner DK; Cordero L
    Am J Obstet Gynecol; 2009 Jan; 200(1):70.e1-5. PubMed ID: 18976737
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Buprenorphine and methadone treatment of opiate dependence during pregnancy: comparison of fetal growth and neonatal outcomes in two consecutive case series.
    Kakko J; Heilig M; Sarman I
    Drug Alcohol Depend; 2008 Jul; 96(1-2):69-78. PubMed ID: 18355989
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Opioid maintenance treatment during pregnancy: occurrence and severity of neonatal abstinence syndrome. A national prospective study.
    Bakstad B; Sarfi M; Welle-Strand GK; Ravndal E
    Eur Addict Res; 2009; 15(3):128-34. PubMed ID: 19332991
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A retrospective study of length of hospital stay in infants treated for neonatal abstinence syndrome with methadone versus oral morphine preparations.
    Lainwala S; Brown ER; Weinschenk NP; Blackwell MT; Hagadorn JI
    Adv Neonatal Care; 2005 Oct; 5(5):265-72. PubMed ID: 16202968
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relationship between maternal methadone dose at delivery and neonatal abstinence syndrome.
    Seligman NS; Almario CV; Hayes EJ; Dysart KC; Berghella V; Baxter JK
    J Pediatr; 2010 Sep; 157(3):428-33, 433.e1. PubMed ID: 20472252
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association between intrapartum fetal heart rate patterns and neonatal abstinence syndrome in methadone exposed neonates.
    Leeman LM; Brown SA; Albright B; Skipper B; Hsi A; Rayburn WF
    J Matern Fetal Neonatal Med; 2011 Jul; 24(7):955-9. PubMed ID: 21142769
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pregnancy outcome in women who use opiates.
    Fajemirokun-Odudeyi O; Sinha C; Tutty S; Pairaudeau P; Armstrong D; Phillips T; Lindow SW
    Eur J Obstet Gynecol Reprod Biol; 2006 Jun; 126(2):170-5. PubMed ID: 16202501
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Methadone treatment during pregnancy and its effect on the child. Better than continuing drug abuse, should be monitored by a specialized antenatal care center].
    Sarman I
    Lakartidningen; 2000 May; 97(18):2182-4, 2187-8, 2190. PubMed ID: 10850047
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Pregnancy and drug dependence].
    Schneider C; Fischer G; Diamant K; Hauk R; Pezawas L; Lenzinger E; Kasper S
    Wien Klin Wochenschr; 1996; 108(19):611-4. PubMed ID: 9012146
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Perinatal risk factors for the neonatal abstinence syndrome in infants born to women on methadone maintenance therapy.
    Liu AJ; Jones MP; Murray H; Cook CM; Nanan R
    Aust N Z J Obstet Gynaecol; 2010 Jun; 50(3):253-8. PubMed ID: 20618243
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Maternal methadone dose during pregnancy and infant clinical outcome.
    Wouldes TA; Woodward LJ
    Neurotoxicol Teratol; 2010; 32(3):406-13. PubMed ID: 20102736
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Drug withdrawal in newborns - clinical data of 49 infants with intrauterine drug exposure: what should be done?].
    Bläser A; Pulzer F; Knüpfer M; Robel-Tillig E; Vogtmann C; Nickel P; Kiess W
    Klin Padiatr; 2008; 220(5):308-15. PubMed ID: 18260044
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Maternal methadone use in pregnancy: factors associated with the development of neonatal abstinence syndrome and implications for healthcare resources.
    Dryden C; Young D; Hepburn M; Mactier H
    BJOG; 2009 Apr; 116(5):665-71. PubMed ID: 19220239
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chronic hepatitis C in pregnancy.
    Berkley EM; Leslie KK; Arora S; Qualls C; Dunkelberg JC
    Obstet Gynecol; 2008 Aug; 112(2 Pt 1):304-10. PubMed ID: 18669727
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Maternal and neonatal factors impacting response to methadone therapy in infants treated for neonatal abstinence syndrome.
    Isemann B; Meinzen-Derr J; Akinbi H
    J Perinatol; 2011 Jan; 31(1):25-9. PubMed ID: 20508596
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sequela of preterm versus term infants born to mothers on a methadone maintenance program: differential course of neonatal abstinence syndrome.
    Dysart K; Hsieh HC; Kaltenbach K; Greenspan JS
    J Perinat Med; 2007; 35(4):344-6. PubMed ID: 17511598
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Methadone maintenance program in pregnancy in a Swiss perinatal center (II): neonatal outcome and social resources.
    Arlettaz R; Kashiwagi M; Das-Kundu S; Fauchère JC; Lang A; Bucher HU
    Acta Obstet Gynecol Scand; 2005 Feb; 84(2):145-50. PubMed ID: 15683374
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.